- Home
- MOLN vs KRMD Comparison
MOLN vs KRMD Comparison
Compare MOLN & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- KRMD
- Stock Information
- Founded
- MOLN 2004
- KRMD 1980
- Country
- MOLN Switzerland
- KRMD United States
- Employees
- MOLN N/A
- KRMD N/A
- Industry
- MOLN
- KRMD Medical/Dental Instruments
- Sector
- MOLN
- KRMD Health Care
- Exchange
- MOLN Nasdaq
- KRMD Nasdaq
- Market Cap
- MOLN 136.1M
- KRMD 134.3M
- IPO Year
- MOLN 2021
- KRMD N/A
- Fundamental
- Price
- MOLN $3.72
- KRMD $3.62
- Analyst Decision
- MOLN
- KRMD Strong Buy
- Analyst Count
- MOLN 0
- KRMD 4
- Target Price
- MOLN N/A
- KRMD $4.63
- AVG Volume (30 Days)
- MOLN 1.8K
- KRMD 456.1K
- Earning Date
- MOLN 08-25-2025
- KRMD 08-06-2025
- Dividend Yield
- MOLN N/A
- KRMD N/A
- EPS Growth
- MOLN N/A
- KRMD N/A
- EPS
- MOLN N/A
- KRMD N/A
- Revenue
- MOLN $2,525,030.00
- KRMD $35,083,740.00
- Revenue This Year
- MOLN N/A
- KRMD $18.16
- Revenue Next Year
- MOLN $866.67
- KRMD $14.60
- P/E Ratio
- MOLN N/A
- KRMD N/A
- Revenue Growth
- MOLN N/A
- KRMD 19.65
- 52 Week Low
- MOLN $3.36
- KRMD $1.86
- 52 Week High
- MOLN $12.22
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- MOLN 49.47
- KRMD 66.17
- Support Level
- MOLN $3.71
- KRMD $3.45
- Resistance Level
- MOLN $3.89
- KRMD $3.77
- Average True Range (ATR)
- MOLN 0.15
- KRMD 0.22
- MACD
- MOLN 0.01
- KRMD 0.02
- Stochastic Oscillator
- MOLN 41.27
- KRMD 75.81
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).